Browsing by Author "Bak Leong Goh"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
- PublicationCapturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes(2020)
;Roberto Pecoits-Filho ;Ikechi G. Okpechi ;Jo-Ann Donner ;David C.H. Harris ;Harith M. Aljubori ;Aminu K. Bello ;Ezequiel Bellorin-Font ;Fergus J. Caskey ;Allan Collins ;Alfonso M. Cueto-Manzano ;John Feehally ;Bak Leong Goh ;Kitty J. Jager ;Masaomi Nangaku ;Muhibur Rahman ;Manisha Sahay ;Abdulkarim Saleh ;Laura Sola ;Rumeyza Turan Kazancioglu ;Rachael C. Walker ;Robert Walker ;Qiang Yao ;Xueqing Yu ;Ming-Hui ZhaoDavid W. JohnsonA large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes - PublicationDeveloping the ethical framework of end-stage kidney disease care: from practice to policy(2020)
;Valerie A. Luyckx ;Dominique E. Martin ;Mohammed Rafique Moosa ;Aminu K. Bello ;Ezequiel Bellorin-Font ;Tak Mao Chan ;Rolando Claure-Del Granado ;Walter Douthat ;Somchai Eiam-Ong ;Felicia U. Eke ;Bak Leong Goh ;Vivekanand Jha ;Evie Kendal ;Adrian Liew ;Yewondwossen Tadesse Mengistu ;Elmi Muller ;Ikechi G. Okpechi ;Eric Rondeau ;Manisha Sahay ;Michele TraskTushar VachharajaniEthical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success. - PublicationDialysis Malnutrition and Malnutrition Inflammation Scores: screening tools for prediction of dialysis-related protein-energy wasting in Malaysia(2016)
;Gilcharan Singh Harvinder ;Winnie Chee Siew Swee ;Tilakavati Karupaiah ;Sharmela Sahathevan ;Karuthan Chinna ;Ghazali Ahmad ;Sunita BavanandanBak Leong GohMalnutrition is highly prevalent in Malaysian dialysis patients and there is a need for a valid screening tool for early identification and management. This cross-sectional study aims to examine the sensitivity of the Dialysis Malnutrition Score (DMS) and Malnutrition Inflammation Score (MIS) tools in predicting protein-energy wasting (PEW) among Malaysian dialysis patients. - PublicationGlobal case studies for chronic kidney disease/end-stage kidney disease care(2020)
;Chih-Wei Yang ;David C.H. Harris ;Valerie A. Luyckx ;Masaomi Nangaku ;Fan Fan Hou ;Guillermo Garcia Garcia ;Hasan Abu-Aisha ;Abdou Niang ;Laura Sola ;Sakarn Bunnag ;Somchai Eiam-Ong ;Kriang Tungsanga ;Marie Richards ;Nick Richards ;Bak Leong Goh ;Gavin Dreyer ;Rhys Evans ;Henry Mzingajira ;Ahmed Twahir ;Mignon I. McCulloch ;Curie Ahn ;Charlotte Osafo ;Hsiang-Hao Hsu ;Lianne Barnieh ;Jo-Ann DonnerMarcello TonelliThe prevalence of chronic kidney disease and its risk factors is increasing worldwide, and the rapid rise in global need for end-stage kidney disease care is a major challenge for health systems, particularly in low- and middle-income countries. Countries are responding to the challenge of end-stage kidney disease in different ways, with variable provision of the components of a kidney care strategy, including effective prevention, detection, conservative care, kidney transplantation, and an appropriate mix of dialysis modalities. This collection of case studies is from 15 countries from around the world and offers valuable learning examples from a variety of contexts. The variability in approaches may be explained by country differences in burden of disease, available human or financial resources, income status, and cost structures. In addition, cultural considerations, political context, and competing interests from other stakeholders must be considered. Although the approaches taken have often varied substantially, a common theme is the potential benefits of multistakeholder engagement aimed at improving the availability and scope of integrated kidney care. - PublicationProtocol for a randomised, open-label, parallel group, multicentre controlled study to evaluate the clinical performance and safety of Stay Safe Link compared with Stay Safe in patients with end-stage kidney disease on continuous ambulatory peritoneal dialysis(2019)
;Wen Yao Mak ;Loke Meng Ong ;Bak Leong Goh ;Sunita Bavanandan ;Lily Mushahar ;Chin Tho LeongLai Seong HooiPeritonitis is a major complication of continuous ambulatory peritoneal dialysis (CAPD), the risk of which is significantly influenced by the type of PD transfer system. Although the Y-disconnect and double-bag system is more efficient in preventing peritonitis compared with the spike system, little information is available to differentiate risks between different brands of the Y-disconnect double-bag system. A randomised controlled trial to evaluate the safety and efficacy of a newly introduced system is needed to provide the necessary clinical evidence to guide policy decision-making. - PublicationStrategic plan for integrated care of patients with kidney failure(Elsevier Inc., 2020)
;David C.H. Harris ;Simon J. Davies ;Fredric O. Finkelstein ;Vivekanand Jha ;Aminu K. Bello ;Mark Brown ;Fergus J. Caskey ;Jo-Ann Donner ;Adrian Liew ;Elmi Muller ;Saraladevi Naicker ;Philip J. O’Connell ;Roberto Pecoits Filho ;Tushar Vachharajani ;Ali K. Abu Alfa ;Gloria Ashuntantang ;Edwina Brown ;Brett Cullis ;Gavin Dreyer ;Felicia U. Eke ;Guillermo Garcia Garcia ;Bak Leong Goh ;Brenda Hemmelgarn ;Fan Fan Hou ;Arpana Iyengar ;David W. Johnson ;Nathan W. Levin ;Valerie A. Luyckx ;Dominique E. Martin ;Mignon I. McCulloch ;Yewondwossesn Tadesse Mengistu ;Mohammed Rafique Moosa ;Rachael L. Morton ;Abdou Niang ;Gregorio T. Obrador ;Ikechi G. Okpechi ;Shahrzad Ossareh ;Kamal D. Shah ;Laura Sola ;Charles Swanepoel ;Irma Tchokhonelidze ;Marcello Tonelli ;Michele Trask ;Rumeyza Turan Kazancioglu ;Ahmed Twahir ;Robert Walker ;Anthony J.O. Were ;Chih-Wei Yang ;Karen Yeates ;Elena ZakharovaCarlos ZunigaThere is a huge gap between the number of patients worldwide requiring versus those actually receiving safe, sustainable, and equitable care for kidney failure. To address this, the International Society of Nephrology coordinated the development of a Strategic Plan for Integrated Care of Patients with Kidney Failure. Implementation of the plan will require engagement of the whole kidney community over the next 5–10 years.